131 related articles for article (PubMed ID: 9734654)
1. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
Vinante F; Rigo A; Tecchio C; Morosato L; Nadali G; Ricetti MM; Krampera M; Zanolin E; Locatelli F; Gallati H; Chilosi M; Pizzolo G
Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
4. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
Lin M; Meng X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):245-8. PubMed ID: 11601213
[TBL] [Abstract][Full Text] [Related]
5. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.
Kallinowski B; Haseroth K; Marinos G; Hanck C; Stremmel W; Theilmann L; Singer MV; Rossol S
Clin Exp Immunol; 1998 Feb; 111(2):269-77. PubMed ID: 9486392
[TBL] [Abstract][Full Text] [Related]
7. High blood soluble receptor p80 for tumour necrosis factor-alpha is associated with erythropoietin resistance in haemodialysis patients.
Kato A; Odamaki M; Takita T; Furuhashi M; Maruyama Y; Hishida A
Nephrol Dial Transplant; 2001 Sep; 16(9):1838-44. PubMed ID: 11522867
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
Itoh Y; Okanoue T; Ohnishi N; Sakamoto M; Nishioji K; Nakagawa Y; Minami M; Murakami Y; Kashima K
Am J Gastroenterol; 1999 May; 94(5):1332-40. PubMed ID: 10235215
[TBL] [Abstract][Full Text] [Related]
9. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
Gao L; Bai L; Nan QZ; Yang XS; Chen K; Wen HP; Lai ZS; Bo L; Zhang YL; Zhang ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
[TBL] [Abstract][Full Text] [Related]
10. Increased serum concentrations of soluble tumor necrosis factor receptors p55 and p75 in early onset neonatal sepsis.
Doellner H; Arntzen KJ; Haereid PE; Aag S; Brubakk AM; Austgulen R
Early Hum Dev; 1998 Oct; 52(3):251-61. PubMed ID: 9808075
[TBL] [Abstract][Full Text] [Related]
11. High levels of sTNFR p75 and TNF alpha in dengue-infected patients.
Hober D; Delannoy AS; Benyoucef S; De Groote D; Wattré P
Microbiol Immunol; 1996; 40(8):569-73. PubMed ID: 8887351
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Warzocha K; Bienvenu J; Ribeiro P; Moullet I; Dumontet C; Neidhardt-Berard EM; Coiffier B; Salles G
Br J Cancer; 1998 Jun; 77(12):2357-62. PubMed ID: 9649158
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
[TBL] [Abstract][Full Text] [Related]
14. Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells.
Carter A; Haddad N; Draxler I; Israeli E; Raz B; Rowe JM
Br J Haematol; 1996 Jan; 92(1):116-26. PubMed ID: 8562381
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
16. Role of tumor necrosis factor receptors TNFR-I (P55) and TNFR-II (P75) in corneal transplantation.
Yamada J; Streilein JW; Dana MR
Transplantation; 1999 Oct; 68(7):944-9. PubMed ID: 10532532
[TBL] [Abstract][Full Text] [Related]
17. Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis.
Kern WV; Oristrell J; Segura-Porta F; Kern P
Clin Diagn Lab Immunol; 1996 Mar; 3(2):233-5. PubMed ID: 8991643
[TBL] [Abstract][Full Text] [Related]
18. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.
Steinshamn S; Brekke OL; Waage A
Br J Haematol; 1995 Apr; 89(4):719-24. PubMed ID: 7772508
[TBL] [Abstract][Full Text] [Related]
19. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
Landmann R; Keilholz U; Scheibenbogen C; Brockhaus M; Gallati H; Denz H; Bargetzi M; Ludwig C
Cancer Immunol Immunother; 1994 Feb; 38(2):113-8. PubMed ID: 8306366
[TBL] [Abstract][Full Text] [Related]
20. Fas-mediated neutrophil apoptosis and associated A1 protein expression during systemic inflammation are regulated independently of both tumor necrosis factor receptors.
Kotani J; Avallone NJ; Lin E; Goshima M; Gandhi K; Lowry SF; Calvano SE
Shock; 2003 Mar; 19(3):201-7. PubMed ID: 12630518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
